Belgium· BE-AMP-SAM345764-00
Luveris 450 IU
A lutropin alfa product containing lutropin alfa, registered in Belgium by Merck Europe. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Lutropin alfa is registered in 12 of 19 countries.
Countries holding a registration under ATC G03GA07 (lutropin alfa), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Lutropin alfa · ATC G03GA07
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Lutropin Alfa
- Manufacturer
- Merck Europe
- Country
- Belgium (BE)
- ATC code
- G03GA07
- ATC class
- Lutropin alfa
- Defined daily dose
- 75 E, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutropin alfa in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandLuverisMerck Europe B.V.
- CzechiaLUVERISMerck Europe B.V., Amsterdam
- ItalyLUVERIS*1 flaconcino SC 75 UI + 1 flaconcino solvMERCK EUROPE BV
- FinlandLuverisMerck Europe B.V.
- FranceLUVERIS 75 UI, poudre et solvant pour solution injectableMERCK EUROPE (PAYS-BAS)
- United KingdomLuveris 75unit powder and solvent for solution for injection vialsMerck Serono Ltd
- IcelandLuverisMerck Europe B.V.*
- PolandLuverisMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Luveris
- Liechtenstein · Luveris
- Norway · Luveris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e8ef738b-9f7a-4c07-805f-44c3c9998da0 GET /v1/drugs/e8ef738b-9f7a-4c07-805f-44c3c9998da0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"source": "afmps",
"status": "REVOKED",
"name_en": "Luveris 450 IU",
"name_fr": "Luveris 450 IU",
"name_nl": "Luveris 450 IU",
"amp_code": "SAM345764-00",
"strengths": [
"450.0000"
],
"pack_count": 1,
"substances": [
"Lutropin Alfa"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Lutropin Alfa",
"authorisation_numbers": [
"EU/1/00/155/007"
]
}See everything about lutropin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.